MiMedx (MDXG)
Processor of donated placental tissue into allografts for wound care and surgical use.
$4.82
vs last close−0.11 (−2.28%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82 | 87 | 85 | 87 | 84 | 93 | 88 | 99 | 114 | 118 | 59 | 64 |
| Cost of revenue | 15 | 14 | 13 | 15 | 15 | 17 | 17 | 19 | 19 | 19 | 17 | 20 |
| Gross profit | 67 | 73 | 72 | 72 | 69 | 76 | 72 | 80 | 95 | 99 | 42 | 44 |
| 56 | 58 | 59 | 49 | 58 | 65 | 63 | 68 | 73 | 78 | 58 | 63 | |
| Research & development | 3 | 2 | 3 | 3 | 3 | 4 | 3 | 3 | 4 | 5 | 4 | 3 |
| 53 | 55 | 55 | 46 | 54 | 61 | 60 | 64 | 69 | 73 | 53 | 60 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48 | 54 | 0 | 44 | 46 |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 15 | 0 | 9 | 13 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 11 | 15 | 13 | 23 | 11 | 11 | 8 | 12 | 22 | 21 | −16 | −18 |
| −2 | −2 | −2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 1 | 0 | 1 | 1 | 0 |
| Interest expense | 2 | 2 | 2 | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 | −1 | −1 | −1 | 0 |
| Income before tax | 9 | 14 | 11 | 23 | 11 | 11 | 9 | 13 | 23 | 22 | −15 | −18 |
| Income tax expense | 1 | −37 | 2 | 6 | 4 | 4 | 2 | 3 | 6 | 7 | −4 | −3 |
| Net income from continuing operations | 9 | 51 | 9 | 18 | 8 | 7 | 7 | 10 | 17 | 15 | −11 | −15 |
| Discontinued operations | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 9 | 53 | 9 | 18 | 8 | 7 | 7 | 10 | 17 | 15 | −11 | −15 |
| EPS, basic | $0.06 | $0.43 | $0.06 | $0.12 | $0.06 | $0.05 | $0.05 | $0.07 | $0.11 | $0.10 | −$0.07 | −$0.10 |
| EPS, diluted | $0.06 | $0.35 | $0.06 | $0.12 | $0.05 | $0.05 | $0.05 | $0.06 | $0.11 | $0.10 | −$0.07 | −$0.10 |
| Weighted average shares, basic | 116 | 119 | 146 | 147 | 147 | 147 | 147 | 148 | 148 | 148 | 148 | 148 |
| Weighted average shares, diluted | 119 | 148 | 150 | 149 | 148 | 149 | 150 | 149 | 150 | 150 | 148 | 148 |
| EBITDA | 12 | 16 | 14 | 24 | 13 | 14 | 12 | 17 | 29 | 25 | −14 | −17 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 5 | 3 | 2 | 2 |
| EBIT | 11 | 16 | 13 | 23 | 11 | 11 | 9 | 13 | 24 | 22 | −15 | −18 |